Adaptive Approach to Naltrexone Treatment for Alcoholism
Naltrexone (NTX) is an opioid receptor antagonist used to prevent alcoholism relapse. This trial examines how to define “non-response” to treatment with NTX and what treatments are most effective for those who do or do not respond to the initial treatment.
Principal Investigator(s): David Oslin
Location: University of Pennsylvania
Funding: NIAAA Project R01AA017164
View all Case Studies HERE.